A detailed history of Exodus Point Capital Management, LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 119,242 shares of CTKB stock, worth $765,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,242
Previous 37,034 221.98%
Holding current value
$765,533
Previous $207,000 219.32%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.73 - $6.73 $388,843 - $553,259
82,208 Added 221.98%
119,242 $661,000
Q2 2024

Aug 13, 2024

BUY
$5.3 - $6.91 $196,280 - $255,904
37,034 New
37,034 $207,000
Q1 2023

May 11, 2023

BUY
$8.44 - $13.47 $1.01 Million - $1.61 Million
119,770 New
119,770 $1.1 Million
Q2 2022

Aug 19, 2022

SELL
$7.41 - $11.56 $200,433 - $312,686
-27,049 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$9.89 - $17.25 $267,514 - $466,595
27,049 New
27,049 $292,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $864M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.